Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Sexual Behavior Patterns and Condom Use in Newly Sexually Active Female University Students.

Fairfortune TS, Stern JE, Richardson BA, Koutsky LA, Winer RL.

Arch Sex Behav. 2019 Aug 12. doi: 10.1007/s10508-019-1411-z. [Epub ahead of print]

PMID:
31407192
2.

Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Xi LF, Schiffman M, Hughes JP, Galloway DA, Koutsky LA, Kiviat NB.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1388-1394. doi: 10.1158/1055-9965.EPI-18-0802. Epub 2019 May 17.

PMID:
31101617
3.

Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.

Fu Xi L, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB.

Int J Cancer. 2017 Apr 15;140(8):1747-1756. doi: 10.1002/ijc.30594. Epub 2017 Jan 24.

4.

Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.

Fu TC, Carter JJ, Hughes JP, Feng Q, Hawes SE, Schwartz SM, Xi LF, Lasof T, Stern JE, Galloway DA, Koutsky LA, Winer RL.

Int J Cancer. 2016 Nov 15;139(10):2201-12. doi: 10.1002/ijc.30283. Epub 2016 Aug 4.

5.

Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia.

Xi LF, Schiffman M, Koutsky LA, Hughes JP, Hulbert A, Shen Z, Galloway DA, Kiviat NB.

Int J Cancer. 2016 Sep 1;139(5):1098-105. doi: 10.1002/ijc.30164. Epub 2016 May 14.

6.

Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years.

Winer RL, Hughes JP, Feng Q, Stern JE, Xi LF, Koutsky LA.

J Infect Dis. 2016 Sep 1;214(5):665-75. doi: 10.1093/infdis/jiw074. Epub 2016 Mar 23.

7.

Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women.

Sadate-Ngatchou P, Carter JJ, Hawes SE, Feng Q, Lasof T, Stern JE, Fu TC, Galloway DA, Koutsky LA, Winer RL.

Sex Transm Dis. 2016 Mar;43(3):192-8. doi: 10.1097/OLQ.0000000000000409.

8.

Detection of Human Papillomavirus Infections at the Single-Cell Level.

Shen Z, Liu X, Morihara J, Hulbert A, Koutsky LA, Kiviat NB, Xi LF.

Intervirology. 2015;58(5):324-331. doi: 10.1159/000442573. Epub 2016 Jan 28.

9.

Epidemiology of Human Papillomavirus Detected in the Oral Cavity and Fingernails of Mid-Adult Women.

Fu TC, Hughes JP, Feng Q, Hulbert A, Hawes SE, Xi LF, Schwartz SM, Stern JE, Koutsky LA, Winer RL.

Sex Transm Dis. 2015 Dec;42(12):677-85. doi: 10.1097/OLQ.0000000000000362.

10.

Association of Human Papillomavirus 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Liu X, Schiffman M, Hulbert A, He Z, Shen Z, Koutsky LA, Xi LF.

J Clin Microbiol. 2015 Nov;53(11):3451-7. doi: 10.1128/JCM.01279-15. Epub 2015 Aug 19.

11.

Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.

Fu TC, Fu Xi L, Hulbert A, Hughes JP, Feng Q, Schwartz SM, Hawes SE, Koutsky LA, Winer RL.

Int J Cancer. 2015 Nov 15;137(10):2432-42. doi: 10.1002/ijc.29602. Epub 2015 May 29.

12.

Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.

Xi LF, Schiffman M, Koutsky LA, Hughes JP, Winer RL, Mao C, Hulbert A, Lee SK, Shen Z, Kiviat NB.

J Natl Cancer Inst. 2014 Sep 13;106(10). pii: dju270. doi: 10.1093/jnci/dju270. Print 2014 Oct.

13.

Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005.

Dunne EF, Flagg EW, Unger ER, Hsu K, Ghanen K, Kerndt P, Shlay JC, Koutsky LA, Datta DS, Panicker G, Zaidi A, Weinstock H, Markowitz LE.

Sex Transm Dis. 2014 Jan;41(1):46-9. doi: 10.1097/OLQ.0000000000000071.

PMID:
24326582
14.

Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals.

Martin E, Dang J, Bzhalava D, Stern J, Edelstein ZR, Koutsky LA, Kiviat NB, Feng Q.

J Clin Virol. 2014 Jan;59(1):30-7. doi: 10.1016/j.jcv.2013.10.028. Epub 2013 Nov 1.

15.

Incidence of oral human papillomavirus infection.

Edelstein ZR, Schwartz SM, Koutsky LA.

Lancet. 2013 Nov 9;382(9904):1554. doi: 10.1016/S0140-6736(13)62326-0. No abstract available.

PMID:
24209828
16.

Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.

Winer RL, Xi LF, Shen Z, Stern JE, Newman L, Feng Q, Hughes JP, Koutsky LA.

Int J Cancer. 2014 Apr 15;134(8):1889-98. doi: 10.1002/ijc.28509. Epub 2013 Oct 18.

17.

High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men.

Glick SN, Feng Q, Popov V, Koutsky LA, Golden MR.

J Infect Dis. 2014 Feb 1;209(3):369-76. doi: 10.1093/infdis/jit441. Epub 2013 Aug 15.

18.

Rates and determinants of oral human papillomavirus infection in young men.

Edelstein ZR, Schwartz SM, Hawes S, Hughes JP, Feng Q, Stern ME, O'Reilly S, Lee SK, Fu Xi L, Koutsky LA.

Sex Transm Dis. 2012 Nov;39(11):860-7. doi: 10.1097/OLQ.0b013e318269d098.

19.

Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.

Winer RL, Hughes JP, Feng Q, Xi LF, Lee SK, O'Reilly SF, Kiviat NB, Koutsky LA.

Sex Transm Dis. 2012 Nov;39(11):848-56. doi: 10.1097/OLQ.0b013e3182641f1c. Erratum in: Sex Transm Dis. 2013 Nov;40(11):898.

20.

Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing.

Wolfrum SG, Koutsky LA, Hughes JP, Feng Q, Xi LF, Shen Z, Winer RL.

J Med Microbiol. 2012 Nov;61(Pt 11):1538-45. doi: 10.1099/jmm.0.046110-0. Epub 2012 Aug 16. Erratum in: J Med Microbiol. 2013 Dec;62(Pt 12):1918.

PMID:
22899778
21.

Disclosure of genital human papillomavirus infection to female sex partners by young men.

Arima Y, Winer RL, Kurth AE, Martin DP, Hughes JP, Stern ME, Feng Q, Kiviat NB, Koutsky LA.

Sex Transm Dis. 2012 Aug;39(8):583-7. doi: 10.1097/OLQ.0b013e318254c982.

22.

Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage.

Xi LF, Schiffman M, Koutsky LA, He Z, Winer RL, Hulbert A, Lee SK, Ke Y, Kiviat NB.

Int J Cancer. 2013 Feb 1;132(3):549-55. doi: 10.1002/ijc.27689. Epub 2012 Jul 11.

23.

Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3.

Xi LF, Schiffman M, Koutsky LA, Hulbert A, Lee SK, Defilippis V, Shen Z, Kiviat NB.

Int J Cancer. 2012 Nov 15;131(10):2300-7. doi: 10.1002/ijc.27520. Epub 2012 Mar 29.

24.

Monitoring HPV type-specific prevalence over time through clinic-based surveillance: a perspective on vaccine effectiveness.

Gaffga NH, Flagg EW, Weinstock HS, Shlay JC, Ghanem KG, Koutsky LA, Kerndt PR, Hsu KK, Unger ER, Datta SD.

Vaccine. 2012 Mar 2;30(11):1959-64. doi: 10.1016/j.vaccine.2012.01.021. Epub 2012 Jan 18.

PMID:
22265859
25.

Evidence of immune memory 8.5 years following administration of a prophylactic human papillomavirus type 16 vaccine.

Rowhani-Rahbar A, Alvarez FB, Bryan JT, Hughes JP, Hawes SE, Weiss NS, Koutsky LA.

J Clin Virol. 2012 Mar;53(3):239-43. doi: 10.1016/j.jcv.2011.12.009. Epub 2011 Dec 30.

26.

Circumcision and acquisition of human papillomavirus infection in young men.

Vanbuskirk K, Winer RL, Hughes JP, Feng Q, Arima Y, Lee SK, Stern ME, O'Reilly SF, Koutsky LA.

Sex Transm Dis. 2011 Nov;38(11):1074-81. doi: 10.1097/OLQ.0b013e31822e60cb.

27.

Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3.

Xi LF, Jiang M, Shen Z, Hulbert A, Zhou XH, Lin YY, Kiviat NB, Koutsky LA.

PLoS One. 2011;6(8):e23897. doi: 10.1371/journal.pone.0023897. Epub 2011 Aug 24.

28.

The association of current hormonal contraceptive use with type-specific HPV detection.

Ghanem KG, Datta SD, Unger ER, Hagensee M, Shlay JC, Kerndt P, Hsu K, Koutsky LA.

Sex Transm Infect. 2011 Aug;87(5):385-8. doi: 10.1136/sextrans-2011-050005.

29.

Serum antibody response following genital {alpha}9 human papillomavirus infection in young men.

Edelstein ZR, Carter JJ, Garg R, Winer RL, Feng Q, Galloway DA, Koutsky LA.

J Infect Dis. 2011 Jul 15;204(2):209-16. doi: 10.1093/infdis/jir242.

30.

Prevalence of high-risk HPV types and abnormal cervical cytology in American Indian/Alaska Native women, 2003-2005.

Alfonsi GA, Datta SD, Mickiewicz T, Koutsky LA, Ghanem K, Hagensee M, Kerndt P, Hsu K, Weinstock H, Shlay JC.

Public Health Rep. 2011 May-Jun;126(3):330-7.

31.

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia.

Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG, Koutsky LA, Sings HL, Lu S, Haupt RM, Paavonen J; FUTURE I and II Study Group.

Sex Transm Infect. 2011 Aug;87(5):372-6. doi: 10.1136/sti.2010.044354. Epub 2011 Apr 6.

32.

Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.

Xi LF, Hughes JP, Castle PE, Edelstein ZR, Wang C, Galloway DA, Koutsky LA, Kiviat NB, Schiffman M.

J Infect Dis. 2011 May 15;203(10):1425-33. doi: 10.1093/infdis/jir049. Epub 2011 Mar 16.

33.

Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.

Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Hernandez-Avila M, Brown DR, Elbasha E, Muñoz N, Paavonen J, Haupt RM; FUTURE I Investigators.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):287-96. doi: 10.1158/1055-9965.EPI-10-0791.

34.

Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Winer RL, Hughes JP, Feng Q, Xi LF, Cherne S, O'Reilly S, Kiviat NB, Koutsky LA.

Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):699-707. doi: 10.1158/1055-9965.EPI-10-1108. Epub 2010 Dec 20.

35.

Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections.

Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Hulbert A, Schiffman M, Kiviat NB.

J Infect Dis. 2010 Dec 1;202(11):1667-70. doi: 10.1086/657083. Epub 2010 Oct 26.

36.

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.

Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Majewski S, Muñoz N, Sings HL, Harkins K, Rutkowski MA, Haupt RM, Garner EI; FUTURE I and II Study Group.

Int J Cancer. 2011 Mar 15;128(6):1344-53. doi: 10.1002/ijc.25723. Epub 2011 Jan 12.

37.

Development of genital warts after incident detection of human papillomavirus infection in young men.

Arima Y, Winer RL, Feng Q, Hughes JP, Lee SK, Stern ME, O'Reilly SF, Koutsky LA.

J Infect Dis. 2010 Oct 15;202(8):1181-4. doi: 10.1086/656368.

PMID:
20812849
38.

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R.

BMJ. 2010 Jul 20;341:c3493. doi: 10.1136/bmj.c3493.

39.

Evaluation of transported dry and wet cervical exfoliated samples for detection of human papillomavirus infection.

Feng Q, Cherne S, Winer RL, Popov V, Zambrano H, Yerovi C, Hawes SE, Koutsky LA, Kiviat NB.

J Clin Microbiol. 2010 Sep;48(9):3068-72. doi: 10.1128/JCM.00736-10. Epub 2010 Jul 7.

40.

Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.

Balasubramanian A, Kulasingam SL, Baer A, Hughes JP, Myers ER, Mao C, Kiviat NB, Koutsky LA.

J Low Genit Tract Dis. 2010 Jul;14(3):185-95. doi: 10.1097/LGT.0b013e3181cd6d36.

41.

Detection of genital HPV types in fingertip samples from newly sexually active female university students.

Winer RL, Hughes JP, Feng Q, Xi LF, Cherne S, O'Reilly S, Kiviat NB, Koutsky LA.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1682-5. doi: 10.1158/1055-9965.EPI-10-0226. Epub 2010 Jun 22.

42.

Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.

Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Brown DR, Elbasha EH, Paavonen J, Haupt RM; FUTURE I Investigators.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1585-94. doi: 10.1158/1055-9965.EPI-09-1235.

43.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
44.

Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load.

Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, Ho J, Schiffman M.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3490-6. doi: 10.1158/1055-9965.EPI-09-0763.

45.

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.

Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Hum Vaccin. 2009 Oct;5(10):696-704. Epub 2009 Oct 1.

PMID:
19855170
46.

Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up.

Xi LF, Hughes JP, Edelstein ZR, Kiviat NB, Koutsky LA, Mao C, Ho J, Schiffman M.

J Infect Dis. 2009 Dec 1;200(11):1789-97. doi: 10.1086/647993.

47.

Evaluation of an ELISA for p16INK4a as a screening test for cervical cancer.

Balasubramanian A, Hughes J, Mao C, Ridder R, Herkert M, Kiviat NB, Koutsky LA.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3008-17. doi: 10.1158/1055-9965.EPI-09-0328. Epub 2009 Oct 20.

48.

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.

Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Lu S, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Cancer Prev Res (Phila). 2009 Oct;2(10):868-78. doi: 10.1158/1940-6207.CAPR-09-0031. Epub 2009 Sep 29.

49.

Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C.

Adelstein DJ, Ridge JA, Gillison ML, Chaturvedi AK, D'Souza G, Gravitt PE, Westra W, Psyrri A, Kast WM, Koutsky LA, Giuliano A, Krosnick S, Trotti A, Schuller DE, Forastiere A, Ullmann CD.

Head Neck. 2009 Nov;31(11):1393-422. doi: 10.1002/hed.21269. No abstract available.

PMID:
19787782
50.

Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.

Rowhani-Rahbar A, Carter JJ, Hawes SE, Hughes JP, Weiss NS, Galloway DA, Koutsky LA.

J Infect Dis. 2009 Nov 1;200(9):1452-5. doi: 10.1086/606026.

Supplemental Content

Loading ...
Support Center